Cargando…
Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients
BACKGROUND: Better breast cancer prognostication may improve selection of patients for adjuvant therapy. We conducted a retrospective follow-up study in which we investigated sera of high-risk primary breast cancer patients, to search for proteins predictive of recurrence free survival. METHODS: Two...
Autores principales: | Gast, Marie-Christine W, van Tinteren, Harm, Bontenbal, Marijke, van Hoesel, René QGCM, Nooij, Marianne A, Rodenhuis, Sjoerd, Span, Paul N, Tjan-Heijnen, Vivianne CG, de Vries, Elisabeth GE, Harris, Nathan, Twisk, Jos WR, Schellens, Jan HM, Beijnen, Jos H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627917/ https://www.ncbi.nlm.nih.gov/pubmed/19108738 http://dx.doi.org/10.1186/1471-2407-8-389 |
Ejemplares similares
-
Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer
por: Gast, Marie-Christine W., et al.
Publicado: (2011) -
Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling
por: Gast, Marie-Christine W, et al.
Publicado: (2008) -
Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005) -
Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006) -
Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment
por: van Andel, Lotte, et al.
Publicado: (2018)